Jul 24 |
Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery
|
Jul 16 |
Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call
|
Jul 11 |
Those who invested in Charles River Laboratories International (NYSE:CRL) five years ago are up 50%
|
Jul 9 |
Charles River (CRL) Teams Up to Aid Stargardt's Disease Therapy
|
Jul 8 |
Charles River to Perform Plasmid Manufacturing for AAVantgarde
|
Jul 5 |
Charles River (CRL) Could be an Apt Pick Right Now: Here's Why
|
Jun 28 |
Charles River Labs downgraded at Argus on cautious biotech spending
|
Jun 27 |
Charles River's (CRL) RMS Growth Aids Amid FX Headwind
|
Jun 26 |
Charles River (CRL) Inks CDMO Deal With Gates Institutes
|
Jun 25 |
Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
|